Literature DB >> 18812181

Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry.

Wan Chan1, Hao Yue, Wing Tat Poon, Yan-Wo Chan, Oliver J Schmitz, Daniel W J Kwong, Ricky N S Wong, Zongwei Cai.   

Abstract

Aristolochic acid (AA), derived from the herbal genus Aristolochia and Asarum, has recently been shown to be associated with the development of nephropathy. Upon enzyme activation, AA is metabolized to the aristolactam-nitrenium ion intermediate, which reacts with the exocyclic amino group of the DNA bases via an electrophilic attack at its C7 position, leading to the formation of the corresponding DNA adducts. The AA-DNA adducts are believed to be associated with the nephrotoxic and carcinogenic effects of AA. In this study, liquid chromatography coupled with electrospray ionization mass spectrometry (LC-MS) was used to identify and quantify the AA-DNA adducts isolated from the kidney and liver tissues of the AA-dosed rats. The deoxycytidine adduct of AA (dC-AA) and the deoxyadenosine-AA adduct (dA-AA) were detected and quantified in the tissues of rats with one single oral dose (5mg or 30mg AA/kg body weight). The deoxyguanosine adduct (dG-AA), however, was detected only in the kidney of rats that were dosed at 30mg AA/kg body weight for three consecutive days. The amount of AA-DNA adducts found in the rats correlated well with the dosage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812181     DOI: 10.1016/j.mrfmmm.2008.08.012

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

1.  Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid.

Authors:  Horacio A Priestap; Carlos de los Santos; J Martin E Quirke
Journal:  J Nat Prod       Date:  2010-12-08       Impact factor: 4.050

2.  A fluorescence-based analysis of aristolochic acid-derived DNA adducts.

Authors:  Victor Romanov; Victoria Sidorenko; Thomas A Rosenquist; Terry Whyard; Arthur P Grollman
Journal:  Anal Biochem       Date:  2012-04-04       Impact factor: 3.365

3.  Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.

Authors:  Byeong Hwa Yun; Thomas A Rosenquist; Viktoriya Sidorenko; Charles R Iden; Chung-Hsin Chen; Yeong-Shiau Pu; Radha Bonala; Francis Johnson; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2012-05-04       Impact factor: 3.739

4.  New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.

Authors:  Byeong Hwa Yun; Viktoriya S Sidorenko; Thomas A Rosenquist; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Toxicol Res (Camb)       Date:  2015-07-01       Impact factor: 3.524

5.  Defining in vivo dose-response curves for kidney DNA adduct formation of aristolochic acid I in rat, mouse and human by an in vitro and physiologically based kinetic modeling approach.

Authors:  Rozaini Abdullah; Sebastiaan Wesseling; Bert Spenkelink; Jochem Louisse; Ans Punt; Ivonne M C M Rietjens
Journal:  J Appl Toxicol       Date:  2020-07-07       Impact factor: 3.446

6.  New Contributions to Asarum Powder on Immunology Related Toxicity Effects in Lung.

Authors:  Yamin Li; Lintao Han; Chunhua Huang; Wangqiang Dai; Guangyu Tian; Fang Huang; Jingjing Li; Jinwei Liu; Qiong Wang; Zhenxiang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-02       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.